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Background: High fat diet (HFD) is a diet containing large amounts of fat consistently. 
The increase dietary fat and cholesterol have a key role in development of health 
problems. Extra virgin olive oil associated with prevention of LDL oxidation, beneficial 
changes in lipid ratios and low risk for Coronary Heart Disease. 
Objective: To determine the anti-inflammatory and anti-oxidant effect  of extra virgin 
olive oil extract to  blood levels of COX-2 and LOX-1 in rats induced by high fat diet. 
Method: This research is used randomized posttest only control group design. Thirty 
Wistar rats were divided into five groups:  group of control (-) which received  normal 
diet and group of control (+) which received  HFD without  EVOO treatment and three 
HFD groups treated by EVOO 1 mL/kg BW/day, 2 mL/kg BW/day and 3 mL/kg BW/day 
orally for 2 months. The blood was collected from rat eyes and serum was collected 
after centrifugation. COX-2 and LOX-1 concentrations were measured by the enzyme 
linked immunosorbent assay (ELISA). 
Results: The result showed higher COX-2 concentrations in groups treated with EVOO 
than control (-) group. COX-2 serum levels of negative control where significantly 
lower than those of rats treated with 2 ml/kg/day (p = 0.047) and 3 ml/kg/day EVOO 
(p = 0.014). The COX-2 serum levels of group received 1 ml/kg/day were significantly 
lower than those of rats received 3 ml/kg/day EVOO (p = 0.027). LOX-1 concentrations 
showed  no significant deference among all groups (p = 0.570). 
Conclusion: It’s demonstrated in this study that extra virgin olive oil extract has only 
minor anti-inflammatory and antioxidant effect in rats with high fat diet. 
 








 High fat diet is a diet which contains more than 35 
percent of calories from fat consistently. The increase 
dietary fat and cholesterol becomes a key role inthe 
development of health problems. According to Health 
Organizations reports, the risk factors of high fat diet 
(cardiovascular disease, atherosclerosis) are the causes 
of more deaths than all other combined causes that 
become the pre-eminent health problem worldwide 
especially in developed countries. Atherosclerosis has 
been related to the immune reactivity-mediated 
disruption of the vascular system, characterized by 
inflammation and dysfunction of the lining of the 
involved blood vessels and to build cholesterol, lipids 
and cellular debris. 
 LOX-1, a receptor for ox-LDL, is present 
primarily on endothelial cells. Ox-LDL stimulates the 
overlying endothelial cells (ECs) to produce adhesion 
molecules, chemotactic proteins such as monocyte 
chemoattractant protein-1(MCP-1). These pro-
inflammatory molecules recruit monocytes and 
lymphocytes to the sub-endothelial region of the 
vessel wall. Cyclooxygenase (COX), the key enzyme 
required for the conversion of arachidonic acid to 
prostaglandins, has an important role in biology and 
disease. COX-2 is normally unexpressed in most cells 
or tissues, but is expressed primarily induced in 
response to inflammatory stimuli by mitogens, growth 
factors, and cytokines. COX-2 has pro-inflammatory 
and anti-inflammatory effects. Macrophages are an 
abundant source of COX-2 enzymatic products, while 
nuclear factor-kappaB (NF-B) is a major 
transcription factor involved in regulation of COX-2 
gene expression. Extravirgin olive oil (EVOO) is 
source of high monounsaturated fat in Mediterranean 
diet.EVOO is considered the best, least processed 
Olive oil. EVOO which has phenolic compound was 
associated with decreased LDL cholesterol, increased 
HDL cholesterol, low risk for CHD. The aim of the 
present study was to observe the effect extra virgin 
olive oil on high fat diet (HFD) Wistar rats by 
measuring blood levels of COX-2 and LOX-1. 
 
MATERIALS AND METHODS 
Design of the Study 
 An experimental animal study using randomized 
posttest only control group design was performed 
from January to March 2014. The animal care was in 
the Laboratorium Penelitian dan Pengujian Terpadu 
(LPPT) at Gadjah Mada University while and the 
blood examination for biomarker (LOX-1 and COX-2) 
measurement was done in the biochemistry 
department in the same University. 
Animals 
 Thirty male Wistar rats (Rattus novergicus) aged 
10 weeks and 150 - 200 grams weight, was obtained 
from and reared at the Animal Laboratory at Gadjah 
Mada University Yogyakarta. The animals were 
divided into five intervention groups, which were fed 
by the following diets: standard diet (negative control 
group), high fat diet (positive control group), high fat 
diet + EVOO 1 mg/kg/day, high fat diet + EVOO 2 
mg/kg/day and high fat diet + EVOO 3 mg/kg/day. 
Before undergoing the interventions, the rats were 
adapted to laboratory conditions for 7 days. The 
interventions were conducted for 60 days, after that 
the rats were sacrificed to take blood through eyes and 
separating serum by using centrifuge. 
Compositions of Animal Food 
 The standard diet consisted of PARS chicken feed 
225 gram (containing water, protein, lipid, fiber, ash, 
calcium, phosphorus, antibiotics, and coccidiostatics), 
flour 100 gram, and water 100 ml. total diet 40 
gram/rat. The high fat diet was a combination of 
standard diet (PARS) 200 gram, flour 100 gram, 
cholesterol 8 gram, cholic acid 0,8 gram, pig oil 40 
ml, water 51,2 ml. Total high fat diet 40 gram/ rat. 
Measurements of COX-2 and LOX-1 
 The ELISA assay was performed based on 
manufacturer guidance. These were in the follow 
steps: after determining the required number of wells, 
a standard curve was prepared, samples and standards 
were added, then the plates were incubated at 37°C for 
60 min and then the plates were washed 5 times, after 
that chromogen solution A and B were added, the 
plates was incubated at 37°C for 10 min for color 
development, finally add stop solution and read. 
Absorbance readings were performed at an optical 
density (OD) at 450nm in a micro plate reader within 
10 min after adding the stop solution, the 
measurements were in ng/mL. 
Statistical analysis 
 Non-normally distributed data were analyzed using 
Kruskal-Wallis test followed by the Mann-Whitney 
test, with significant level or probability value 0,05 (p 
= 0,05) and confidence interval 95% (α = 0,05). 
Ethical clearance 
 This study was accorded ethical clearance by the 
Commission of Medical and Health Research Medical 
Faculty Diponegoro University with ethical clearance 
letter under number 176/EC/FK-RSDK/2014. 
 
RESULTS 
 COX-2 serum concentration: The result of this 
study showed a higher COX-2 concentrations in 
groups treated with EVOO than control group (Table 
1). Shapiro-Wilk test showed that data of most groups 
in this study had normal distribution (p > 0.05). 
Except group that received EVOO 1ml/kg/day (p < 
0.05). COX-2 data in group receive 1 mL/kg/day have 
not normal by distributed. This therefore COX-2 data 
were analyzed using Kruskal-Wallis test.  
 This analysis showed a significant difference of 
COX-2 levels among groups (p = 0.046). Mann-
Whitney test indicated that the COX-2 serum levels of 
negative control where significantly lower than those 
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of rats treated with 2 ml/kg/day (p = 0.047) and 3 
ml/kg/day EVOO (p = 0.014). The COX-2 serum 
levels of group received 1 ml/kg/day were 
significantly lower than those of rats received 3 
ml/kg/day EVOO (p = 0.027). 
 
Table 1. COX-2 Levels among Groups. 
Group Mean (SD)Ng/ml 
Negative  control 2.5 ± 0.49 
Positive control 2.9 ± 0.69 
Treatment 1  3.2 ± 0.16 
Treatment 2  3.3 ± 0.47 
Treatment 3  3.7± 0.27 
Note: Negative control (Standard diet); positive 
control (HFD); Treatment 1 (HFD + 1ml olive oil); 
Treatment 2 (HFD + 2ml olive oil); Treatment 3 (HFD 
+ 3ml olive oil). Significant (p < 0.05). 
LOX-1 serum concentration: Shapiro-Wilk test 
showed that the data was normally distributed in each 
groups (p > 0.05). The test of homogeneity of 
variances use Levene's test showed non homogeneity 
(p = 0.016). LOX-1 levels analyzed using Kruskal-
Wallis test, were not significantly deferent among all 
groups (p = 0.570). 
Table 2. LOX-1 Levels among Groups. 
Group Mean (SD)Ng/ml 
Negative  control 1.9 ± 0.31 
Positive control 2.3 ± 0 .39 
Treatment 1  2.4 ± 0.49 
Treatment2  2.4 ± 0 .47 
Treatment3  2.4 ± 0.99 
Note: Negative control (Standard diet); positive 
control (HFD); Treatment 1 (HFD + 1ml olive oil); 
Treatment 2 (HFD + 2ml olive oil); Treatment 3 (HFD 
+ 3ml olive oil). Significant (p<0.05).  
DISCUSSION 
 Consumption of HFD together with EVOO in dose 
of 2 and 3 ml/ kg BW/ day result in significantly 
higher serum COX-2 levels than those consuming 
normal diet only. Significantly higher COX-2 levels 
were found in HFD group receiving EVOO in dose of 
3 ml than 1 ml/ kg BW/ day. These findings were 
unexpected. Several compounds representing those in 
olive oil were able to impair the AA release, 
cyclooxygenase-2 (COX-2) expression, and 
prostaglandin E(2)/ leukotriene B(4) synthesis in 
PMA-stimulated RAW 264.7.
15
 Whole blood in vitro 
study showed the ability of several phenolic of EVOO 
in reducing pro-inflammatory cytokines and 
prostaglandin E2 production.
16
 EVOO is considered as 
fatty acid-rich diets. The long-term ingestion of a diet 
high fat contained in EVOO results in obesity and 
insulin resistance but protects endothelial function in 
rats.
17
 Mechanisms involve in increasing COX-2 
levels remain unclear and need to be elucidated in rats 
consuming a combination of EVOO and HFD. The 
vascular endothelial functions and metabolic 
syndrome should be further studied in rats consumed a 
combination of EVOO and HFD.  
 HFD used in this study did not have significant 
impact in increasing LOX-1. Previous studies showed 
that high fat diet increased oxidized LDL that 
activated LOX-1 to trigger the formation of reactive 
oxygen compounds to block PI3K.
18
 ox-LDL is a 
crucial parameter in evaluating atherosclerotic 
disease.
6
 Polyphenols are able to prevent LDL 
oxidation and platelet aggregation and to inhibit LOX 
and eicosanoid production.
18
 Pretreatment of 
endothelial cells with statins reduces oxLDL-induced 
LOX-1 expression.
19
oxLDL easily enters into the 
monocyte–macrophages of the arterial wall and 
promote the atherosclerotic process.
20
 ox-LDL has 
been shown to upregulate and activation expression of 
LOX-1.
19
 Previous study showed oxidative stress 
markers decreased linearly with increasing phenolic 
content of the olive oil, particularly in markers that are 
directly associated with LDL oxidation.
21
 
 In this study HFD rats that received oral 
administration of EVOO extract had no significant 
different of LOX-1 concentration than those of groups 
without administration of EVOO extract. LOX-1 
released in soluble form (sLOX-1).
22
 Serum sLOX-1 
is increased at an earlier stage of acute coronary 
syndrome (ACS).
23
 ELISA measured sLOX-1 
specifically and sensitively in human serum/plasma 
and can be used as a diagnostic test for ACS at the 
earliest stage.
24
 HFD rats in this study therefore might 
not develop ACS yet. 
 This study is the first evidence that examined the 
protective effect of EVOO through the events of 
inflammation by giving the HFD with the treatment at 
the same time. The results showed that the EVOO 
might not play role in protecting blood vessels of 
individual consuming HFD. Further study need to be 
done to strengthen the recent findings, these are 
analyzing several variables including the cytokines of 
vascular wall and foam cells. Studies in humans are 
warranted due to the complexity of fats intake by 
human and different absorption of olive oil phenols 
among human and animal model. 
CONCLUSIONS 
 In short, after following all steps in relation to 
analyze the data in order to find out the result for 
answering the research question, the result showed 
that there is higher COX-2 level in HFD rats treated 
with 2,3 ml/kg/day EVOO extract was significantly 
higher than HFD rats treated with 1 ml/kg/day EVOO 
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and control group. While LOX-1 level in HFD rats 
treated with extra virgin olive oil extract was not 
significantly different than HFD rats without extra 
virgin olive oil extract. It is clearly that extra virgin 
olive oil extract might have minor anti inflammatory 
and antioxidant effect in rats. 
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